Aptus Capital Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $845K | Sell |
|
|||||
|
2025
Q2 | $794K | Sell |
|
|||||
|
2025
Q1 | $1.01M | Sell |
|
|||||
|
2024
Q4 | $1.14M | Buy |
|
|||||
|
2024
Q3 | $1.02M | Buy |
|
|||||
|
2024
Q2 | $990K | Buy |
|
|||||
|
2024
Q1 | $869K | Buy |
|
|||||
|
2023
Q4 | $684K | Sell |
|
|||||
|
2023
Q3 | $662K | Buy |
|
|||||
|
2023
Q2 | $355K | Buy |
|
|||||
|
2023
Q1 | $373K | Buy |
|
|||||
|
2022
Q4 | $262K | Sell |
|
|||||
|
2022
Q3 | $347K | Sell |
|
|||||
|
2022
Q2 | $300K | Sell |
|
|||||
|
2022
Q1 | $404K | Buy |
|